Cirrhosis differential diagnosis
Cirrhosis Microchapters |
Diagnosis |
---|
Treatment |
Case studies |
Cirrhosis differential diagnosis On the Web |
American Roentgen Ray Society Images of Cirrhosis differential diagnosis |
Risk calculators and risk factors for Cirrhosis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]}
Overview
Cirrhosis can present in a similar way to some other diseases. History, physical examination, and diagnostic testing can help to differentiate cirrhosis from other diseases such as malignancy, constrictive pericarditis, Budd-Chiari syndrome, portal vein thrombosis and splenic vein thrombosis.
Differentiating Cirrhosis from other Diseases
Condition | Differentiating Signs and Symptoms | Differentiating Tests |
Constrictive pericarditis | Increased jugular venous pressure, atrial fibrillation, and tachycardia. Quiet heart sounds with a third heart sound (ventricular knock) present. | EKG will show tachycardia, atrial fibrillation, low-voltage QRS complexes and T wave abnormalities. Doppler ultrasound will show ventricular filling abnormalities. |
Budd-Chiari Syndrome | Abdominal pain, diarrhea, and worsening ascites. | Doppler ultrasound and CT of the abdomen will show absence of the hepatic vein filling. Abdominal CT will show a rapid clearing of the caudate lobe of the liver. |
Splenic vein thrombosis | Similar signs and symptoms of acute pancreatitis with upper abdominal pain radiating to the back, vomiting, poor bowel sounds, fever and shock. Cullen's sign and Grey-Turner's sign may be present. | An ultrasound of the abdomen and CT will show evidence of a splenic vein thrombosis. Normal hepatic venous pressure gradient is present. |
Portal vein thrombosis | Will depend on the underlying cause. If pancreatitis is present, upper abdominal pain radiating to the back, vomiting, poor bowel sounds, fever and shock. Cullen's sign and Grey-Turner's sign may be present. If the cause is ascending cholangitis, fever, rigors, right upper quadrant pain, dark urine, and pale stools may be seen. If abdominal sepsis is the cause, fever, abdominal pain and other signs of peritonitis will be seen. | Doppler ultrasound and abdominal CT will show a portal vein filling defect, and absence of flow in the portal vein. MR or direct angiography will show a normal hepatic venous pressure gradient. |
Schistosomiasis | History of travel to endemic areas. Constitutional symptoms such as malaise, rigors, anorexia, weight loss, vomiting, diarrhea, headache, muscular aches, weakness and abdominal pain. Also urticaria, fever and lymphadenopathy may be seen. | MR or direct angiography will show a normal hepatic venous pressure gradient. |
Sarcoidosis | Dry cough with dyspnea. Anterior or posterior uveitis, dry eyes and glaucoma. Skin findings may include maculopapular lesions on the face, back, arms and legs, and erythema nodosum on the legs. | Chest x ray may show hilar lymphadenopathy, upper lobe fibrosis, and diffuse reticulonodular shadowing. Liver biopsy will show non-necrotizing, non-caseating granulomas. |
Inferior vena cava obstruction | Signs and symptoms of renal cell carcinoma, with hematuria, flank pain, flank or abdominal mass, weight loss and hypertension. | Ultrasound of the abdomen will show evidence of inferior vena cava obstruction. |
Nodular regenerative hyperplasia | None | Liver biopsy will show small regenerative nodules with little or no fibrosis on reticulin staining. |
Idiopathic portal hypertension (hepatoportal sclerosis) | None | Liver biopsy will show no evidence of cirrhosis. |
Vitamin A intoxication, arsenic, and vinyl chloride toxicity | None | History generally reveals exposure. |
Differentiating Cirrhosis from other Diseases Based on Ascitic Fluid
Ascites may be caused by portal hypertension due to cirrhosis of liver or due to other causes such as malignancy.Ascitic fluid analysis should be done to broadly categorize the cause of ascites.
Ascites is broadly classified as two types based on the serum-ascites albumin gradient (SAAG):
- Transudate - SAAG > 1.1 g/dL (indicates the ascites is due to portal hypertension).
- Exudate - SAAG < 1.1 g/dL (indicates the ascites is due to non-portal hypertension etiology).
Less common differentials
Cirrhosis should also be differentiated from other causes of hyperprolactinemia that may present as galactorrhea, amenorrhea, (in females) and infertility (in both males and females) including:
- Physiological:
- Pathological:
- Pituitary tumors (other than prolactinoma):[2]
- Suprasellar tumors (tumors present in the region of the pituitary stalk)
- Hypothyroidism[3]
- Chronic renal failure[4]
- Liver disease[5]
- Cirrhosis (with or without encephalopathy)
- Viral hepatitis (with encephalopathy)
- Seizure disorder[6][7]
- Medication-induced:
- Antipsychotic medications:[8]
- Antiemetic medications:
- Antihypertensive medications:
Disease | Clinical Findings | Laboratory findings | Management |
---|---|---|---|
Somatotroph adenoma: | Clinical features of acromegaly are due to high level of human growth hormone (hGH):
|
|
|
Corticotroph adenoma: Cushing's syndrome | Clinical features of Cushing's syndrome are due to increased levels of cortisol:
|
|
|
Hypothyroidism | Clinical features of hypothyroidism are due to deficiency of thyroxine:
|
|
Levothyroxine |
Chronic renal failure | There are no pathognomonic symptoms associated with chronic renal failure. Common non-specific symptoms of chronic renal failure include:
|
Urinalysis:
Fluid and electrolyte disturbances: Endocrine and metabolic disturbances:
Hematologic abnormalities: |
|
Liver disease: Cirrhosis | The clinical features of liver cirrhosis are very nonspecific. These include:
|
|
|
Seizure disorder | The clinical features of seizure disorder may include:
|
Electroencephalogram |
|
Medication-induced | Clinical features of hyperprolactinemia after a specific period of regular medication ingestion | Discontinuation of the medication for 3 days and remeasurement of prolactin levels[13] | Change to alternate medication |
References
- ↑ Rigg LA, Lein A, Yen SS (1977). "Pattern of increase in circulating prolactin levels during human gestation". Am J Obstet Gynecol. 129 (4): 454–6. PMID 910825.
- ↑ Levy A (2004). "Pituitary disease: presentation, diagnosis, and management". J Neurol Neurosurg Psychiatry. 75 Suppl 3: iii47–52. doi:10.1136/jnnp.2004.045740. PMC 1765669. PMID 15316045.
- ↑ Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH (1973). "Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone". J Clin Invest. 52 (9): 2324–9. doi:10.1172/JCI107421. PMC 333037. PMID 4199418.
- ↑ Sievertsen GD, Lim VS, Nakawatase C, Frohman LA (1980). "Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure". J Clin Endocrinol Metab. 50 (5): 846–52. doi:10.1210/jcem-50-5-846. PMID 7372775.
- ↑ Jha SK, Kannan S (2016). "Serum prolactin in patients with liver disease in comparison with healthy adults: A preliminary cross-sectional study". Int J Appl Basic Med Res. 6 (1): 8–10. doi:10.4103/2229-516X.173984. PMC 4765284. PMID 26958514.
- ↑ Ben-Menachem, Elinor (2006). "Is Prolactin a Clinically Useful Measure of Epilepsy?". Epilepsy Currents. 6 (3): 78–79. doi:10.1111/j.1535-7511.2006.00104.x. ISSN 1535-7597.
- ↑ Trimble MR (1978). "Serum prolactin in epilepsy and hysteria". Br Med J. 2 (6153): 1682. PMC 1608938. PMID 737437.
- ↑ David SR, Taylor CC, Kinon BJ, Breier A (2000). "The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia". Clin Ther. 22 (9): 1085–96. doi:10.1016/S0149-2918(00)80086-7. PMID 11048906.
- ↑ McCallum RW, Sowers JR, Hershman JM, Sturdevant RA (1976). "Metoclopramide stimulates prolactin secretion in man". J Clin Endocrinol Metab. 42 (6): 1148–52. doi:10.1210/jcem-42-6-1148. PMID 777023.
- ↑ Sowers JR, Sharp B, McCallum RW (1982). "Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man". J Clin Endocrinol Metab. 54 (4): 869–71. doi:10.1210/jcem-54-4-869. PMID 7037817.
- ↑ Steiner J, Cassar J, Mashiter K, Dawes I, Fraser TR, Breckenridge A (1976). "Effects of methyldopa on prolactin and growth hormone". Br Med J. 1 (6019): 1186–8. PMC 1639736. PMID 1268617.
- ↑ Fearrington EL, Rand CH, Rose JD (1983). "Hyperprolactinemia-galactorrhea induced by verapamil". Am J Cardiol. 51 (8): 1466–7. PMID 6682619.
- ↑ Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA; et al. (2011). "Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline". J Clin Endocrinol Metab. 96 (2): 273–88. doi:10.1210/jc.2010-1692. PMID 21296991.